REGN vs. QQQ

Last updated Jun 3, 2026

REGN (Regeneron Pharmaceuticals, Inc.) is a stock, while QQQ (Invesco QQQ ETF) is Nasdaq-100 fund tracking the NASDAQ-100 Index. Over the past 10 years, REGN returned 4.25%/yr vs 21.97%/yr for QQQ. At a 0.44 correlation, their price movements are largely independent.

Performance

REGN vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and Invesco QQQ ETF (QQQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, REGN achieves a -21.68% return, which is significantly lower than QQQ's 21.62% return. Over the past 10 years, REGN has underperformed QQQ with an annualized return of 4.25%, while QQQ has yielded a comparatively higher 21.97% annualized return.

REGN

• 1D: 0.38%
• 1M: -13.91%
• YTD: -21.68%
• 6M: -18.52%
• 1Y: 23.51%
• 3Y*: -6.34%
• 5Y*: 3.75%
• 10Y*: 4.25%

QQQ

• 1D: 0.46%
• 1M: 10.68%
• YTD: 21.62%
• 6M: 20.27%
• 1Y: 43.30%
• 3Y*: 28.89%
• 5Y*: 18.43%
• 10Y*: 21.97%

*Multi-year figures are annualized to reflect compound growth (CAGR)

REGN vs. QQQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
REGN Regeneron Pharmaceuticals, Inc.	-21.68%	8.96%	-18.90%	21.73%	14.25%	30.72%	28.66%	0.53%	-0.65%	2.42%
QQQ Invesco QQQ ETF	21.62%	20.77%	25.58%	54.86%	-32.58%	27.42%	48.62%	38.96%	-0.13%	32.66%

Correlation

The correlation between REGN and QQQ is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.31
Correlation (10Y) Calculated over the trailing 10-year period	0.37
Correlation (All Time) Calculated using the full available price history since Mar 11, 1999	0.44

Over the past year, the correlation between REGN and QQQ has dropped to 0.14 - well below their long-term average of 0.44, suggesting their price drivers have been diverging.

Return for Risk

REGN vs. QQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REGN

REGN Risk / Return Rank: 61
REGN Sharpe Ratio Rank: 63
REGN Sortino Ratio Rank: 58
REGN Omega Ratio Rank: 57
REGN Calmar Ratio Rank: 60
REGN Martin Ratio Rank: 68

QQQ

QQQ Risk / Return Rank: 77
QQQ Sharpe Ratio Rank: 83
QQQ Sortino Ratio Rank: 78
QQQ Omega Ratio Rank: 77
QQQ Calmar Ratio Rank: 73
QQQ Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

REGN vs. QQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	REGN	QQQ	Difference
Sharpe ratio Return per unit of total volatility	0.72	2.73	-2.01
Sortino ratio Return per unit of downside risk	1.23	3.55	-2.32
Omega ratio Gain probability vs. loss probability	1.15	1.47	-0.31
Calmar ratio Return relative to maximum drawdown	0.91	3.71	-2.80
Martin ratio Return relative to average drawdown	3.30	14.30	-10.99
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

REGN vs. QQQ - Sharpe Ratio Comparison

The current REGN Sharpe Ratio is 0.72, which is lower than the QQQ Sharpe Ratio of 2.73. The chart below compares the historical Sharpe Ratios of REGN and QQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	REGN	QQQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.72	2.73	-2.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.12	0.83	-0.71
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	0.99	-0.86
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.41	-0.25

Drawdowns

REGN vs. QQQ - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for REGN and QQQ.

Drawdown Indicators

	REGN	QQQ	Difference
Max Drawdown Largest peak-to-trough decline	-91.81%	-82.97%	-8.84%
Max Drawdown (1Y) Largest decline over 1 year	-25.85%	-11.96%	-13.89%
Max Drawdown (3Y) Largest decline over 3 years	-59.69%	-22.77%	-36.92%
Max Drawdown (5Y) Largest decline over 5 years	-59.69%	-35.12%	-24.57%
Max Drawdown (10Y) Largest decline over 10 years	-59.69%	-35.12%	-24.57%
Current Drawdown Current decline from peak	-49.42%	0.00%	-49.42%
Average Drawdown Average peak-to-trough decline	-42.38%	-32.79%	-9.59%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.16%	3.11%	+4.05%

Volatility

REGN vs. QQQ - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 12.02% compared to Invesco QQQ ETF (QQQ) at 4.48%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	REGN	QQQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.02%	4.48%	+7.54%
Volatility (6M) Calculated over the trailing 6-month period	22.49%	12.11%	+10.38%
Volatility (1Y) Calculated over the trailing 1-year period	32.72%	15.95%	+16.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.75%	22.39%	+8.36%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.16%	22.30%	+9.86%

Dividends

REGN vs. QQQ - Dividend Comparison

REGN's dividend yield for the trailing twelve months is around 0.60%, more than QQQ's 0.38% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
QQQ Invesco QQQ ETF	0.38%	0.45%	0.56%	0.62%	0.80%	0.43%	0.55%	0.74%	0.91%	0.84%	1.06%	0.99%
REGN Regeneron Pharmaceuticals, Inc.	0.60%	0.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both REGN and QQQ in my portfolio?

REGN and QQQ have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, REGN or QQQ?

REGN has higher volatility (12.02%) compared to QQQ (4.48%). In terms of maximum drawdown, REGN dropped -91.81% vs QQQ's -82.97%.

Which has better risk-adjusted returns?

QQQ currently has the higher Sharpe Ratio (2.73 vs 0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.